History
  • No items yet
midpage
996 F.3d 243
4th Cir.
2021
Read the full case

Background

  • Arlington County sued numerous opioid manufacturers, distributors, and pharmacies, alleging they caused a local opioid epidemic and seeking substantial monetary relief; ESI Mail Pharmacy and Express Scripts Pharmacy, Inc. (the “ESI Defendants”) were added as mail-order pharmacies.
  • Express Scripts, Inc. (a distinct corporate affiliate) held a Department of Defense (DOD) contract to administer TRICARE Mail Order Pharmacy (TMOP); the ESI Defendants operated TMOP as subcontractors under a detailed Statement of Work (SOW).
  • ESI removed the state-court suit under 28 U.S.C. § 1442(a)(1) (federal-officer removal), arguing they acted under DOD’s direction, had colorable federal defenses (government-contractor immunity and preemption), and the claims related to government-directed conduct.
  • The district court remanded, finding ESI’s interactions with DOD too attenuated and peripheral to satisfy the “acting under” requirement and declined to decide the other two removal prongs.
  • On appeal the Fourth Circuit reviewed jurisdiction de novo, held that ESI met the “acting under” requirement (subcontract performance under a detailed SOW, audits/oversight, statutory duty of DOD to contract), and addressed the remaining two prongs for judicial economy.
  • The Fourth Circuit concluded ESI raised colorable federal defenses (government-contractor immunity and TRICARE preemption) and that Arlington’s claims “relate to” ESI’s government-directed conduct; it reversed and remanded.

Issues

Issue Plaintiff's Argument Defendant's Argument Held
Whether ESI was “acting under” a federal officer for § 1442(a)(1) removal ESI lacked privity with DOD, had no direct contract, and interactions with DOD were too attenuated ESI administered TMOP pursuant to Express Scripts’ DOD SOW, followed DOD formulary and detailed requirements, and were subject to audits/oversight ESI satisfied “acting under”; subcontractor status/privity not dispositive where relationship involves detailed regulation, monitoring, or supervision
Whether ESI has a colorable government-contractor immunity defense Immunity unavailable because no direct contract approval or authority to modify contract terms Government approved precise specifications (SOW/formulary), ESI conformed to them, and plausibly lacked greater knowledge than government Government-contractor immunity is a plausible (colorable) defense for jurisdictional purposes
Whether federal preemption under TRICARE bars Arlington’s state-law claims Arlington’s complaint does not plead claims tied to TMOP, veterans, or the DOD contract TRICARE statute and contract/regulations may preempt state laws to the extent claims conflict with contract/formulary requirements Preemption is a plausible (colorable) defense sufficient for removal jurisdiction
Whether Arlington’s claims “relate to” government-directed conduct (nexus) and whether appellate resolution is appropriate Complaint does not mention TMOP/DOD; alleged harms are to the public, not veterans—no causal relation ESI’s filling of prescriptions under the DOD formulary and SOW is directly tied to the conduct complained of The claims “relate to” government-directed conduct; appellate court exercised discretion to resolve remaining prongs for judicial economy

Key Cases Cited

  • Watson v. Philip Morris Cos., 551 U.S. 142 (U.S. 2007) (scope of “acting under” and limits on mere regulatory compliance)
  • Willingham v. Morgan, 395 U.S. 402 (U.S. 1969) (historical purpose of federal-officer removal)
  • Sawyer v. Foster Wheeler LLC, 860 F.3d 249 (4th Cir. 2017) (private-contractor “acting under” precedent)
  • Mayor & City Council of Baltimore v. BP P.L.C., 952 F.3d 452 (4th Cir. 2020) (standards for reviewing federal-officer removal; liberal construction)
  • Ripley v. Foster Wheeler LLC, 841 F.3d 207 (4th Cir. 2016) (government-contractor immunity framework)
  • Isaacson v. Dow Chem. Co., 517 F.3d 129 (2d Cir. 2008) (definition and low bar for a “colorable federal defense”)
  • Mesa v. California, 489 U.S. 121 (U.S. 1989) (federal defense must be based in federal law)
  • Arizona v. Manypenny, 451 U.S. 232 (U.S. 1981) (defense must arise out of official duties)
  • In re Nat’l Prescription Opiate Litig., 327 F. Supp. 3d 1064 (N.D. Ohio 2018) (MDL decision finding government-contractor defense plausible for opioid distributor defendants)
Read the full case

Case Details

Case Name: County Board of Arlington Co. v. Express Scripts Pharmacy, Inc.
Court Name: Court of Appeals for the Fourth Circuit
Date Published: May 3, 2021
Citations: 996 F.3d 243; 20-1031
Docket Number: 20-1031
Court Abbreviation: 4th Cir.
Log In
    County Board of Arlington Co. v. Express Scripts Pharmacy, Inc., 996 F.3d 243